Custom Antibody Market Report 2026

Custom Antibody Market Overview

• Custom Antibody market size has reached to $0.47 billion in 2025 • Expected to grow to $0.86 billion in 2030 at a compound annual growth rate (CAGR) of 12.8% • Growth Driver: Growing Demand For Personalized Medicine Driving The Market • Market Trend: Increasing Adoption Of AI In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Custom Antibody Market?

A custom antibody is a laboratory-produced antibody specifically designed and generated to target a particular antigen of interest. These antibodies are tailored for research, diagnostic, or therapeutic applications based on the unique needs of scientists or healthcare professionals. Custom antibodies are widely used in biomedical research, diagnostics, and drug development, enabling precise detection and targeting of biomolecules. The main types of custom antibodies in the custom antibody are monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and other types. Monoclonal antibodies are lab-engineered molecules designed to target a specific antigen, mimicking the immune system's pathogen-fighting ability. The services in this market include antibody development, antibody production and purification, and antibody fragmentation and labeling. The sources of custom antibodies include mice, rabbits, and other sources. These antibodies are used in various applications, including oncology, infectious diseases, neurology, stem cells, immunology, and cardiovascular diseases. The key end users of custom antibodies are pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and hospitals and clinics.

What Is The Custom Antibody Market Growth Forecast?

The custom antibody market size is expected to see rapid growth in the next few years. It will grow to $0.86 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to growth in personalized medicine, expansion of biologics research, increasing cro utilization, rising diagnostic demand, growth in precision oncology. Major trends in the forecast period include rising demand for tailored research antibodies, increasing use in precision diagnostics, growing adoption in drug discovery pipelines, expansion of recombinant antibody technologies, increased outsourcing to cros.

Global Custom Antibody Market Segmentation

1) By Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Other Types 2) By Service: Antibody Development, Antibody Production And Purification, Antibody Fragmentation And Labeling 3) By Source: Mice, Rabbit, Other Sources 4) By Application: Oncology, Infectious Diseases, Neurology, Stem Cells, Immunology, Cardiovascular Diseases, Other Applications 5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organization, Hospitals And Clinics Subsegments: 1) By Monoclonal Antibodies: Murine Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies 2) By Polyclonal Antibodies: Rabbit Polyclonal Antibodies, Goat Polyclonal Antibodies, Sheep Polyclonal Antibodies, Other Animal-Derived Polyclonal Antibodies 3) By Recombinant Antibodies: Single-Chain Variable Fragment (scFv), Nanobodies, Bispecific Antibodies, Antibody Fragments 4) By Other Types: Aptamers, Nanobodies (Camelid Antibodies), Hybridomas

What Is The Driver Of The Custom Antibody Market?

The growing demand for personalized medicine is expected to propel the growth of the custom antibody market going forward. Personalized medicine refers to a medical approach that tailor's treatment and prevention strategies to an individual's genetic makeup, lifestyle, and environmental factors. The growing demand for personalized medicine is attributed to advancements in genomics, increased availability of biomarker-based therapies, and rising consumer preference for tailored treatment options that improve efficacy and reduce adverse effects. Custom antibody enables personalized medicine by providing particular and tailored immune reagents that enhance disease detection, therapeutic targeting, and biomarker identification for individualized treatment strategies. For instance, in February 2024, Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, an increase from 6 in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the custom antibody industry.

Key Players In The Global Custom Antibody Market

Major companies operating in the custom antibody market are Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, GenScript Biotech Corporation, BioLegend Inc., Abcam plc, Cusabio Biotech Co. Ltd., OriGene Technologies Inc., Cell Signaling Technology Inc., Abgent Inc., ProSci Incorporated, Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Biolabs Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Biorbyt Ltd., BIOTEM SAS, Capra Biosciences Inc., Pacific Immunology Inc., ProteoGenix SAS

Global Custom Antibody Market Trends and Insights

Major companies operating in the custom antibody market are focusing on integrating innovative technologies such as artificial intelligence to enhance antibody discovery, improve specificity, and accelerate development processes. Artificial intelligence supports custom antibody development by enhancing antigen selection, predicting antibody-antigen binding, and streamlining candidate screening with machine learning, leading to faster and more cost-effective biopharmaceutical research. For instance, in October 2024, Archon Biosciences Inc., a US-based biotechnology company, launched with $20 million in funding to develop computationally designed antibody cages that enable the customization of existing antibodies for therapeutic applications. Archon’s proprietary technology assembles antibodies into cage structures, allowing modifications to their properties without altering their core structures. This innovation aims to enhance antibody affinity for therapeutic targets while reducing off-target interactions, improving efficacy and safety.

What Are Latest Mergers And Acquisitions In The Custom Antibody Market?

In September 2024, Leinco Technologies Inc., a US-based biotechnology company, acquired QED Biosciences Inc. for an undisclosed amount. With this acquisition, Leinco Technologies will advance its strategic growth, expand its presence, and enhance its offerings in the life science and IVD raw material markets. QED Bioscience Inc. is a US-based biotechnology company specializing in designing and manufacturing custom antibodies.

Regional Insights

North America was the largest region in the custom antibody market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Custom Antibody Market?

The custom antibody market consists of revenues earned by entities by providing services such as antibody production, antibody purification, and conjugation. The market value includes the value of related goods sold by the service provider or included within the service offering. The custom antibody market also consists of sales of products including antibody fragments, conjugated antibodies, and secondary antibodies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Custom Antibody Market Report 2026?

The custom antibody market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the custom antibody industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.